Muscimol as an Ionotropic GABA Receptor Agonist

Neurochemical Research

Volumn 39, Issue 10, 2014, Pages 1942-1947

  Johnston, Graham A R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

GABA; GABA receptors; GABA transporters; Muscimol

Indexed keywords

1 [2 (BENZHYDRYLIDENEAMINOOXY)ETHYL] 1,2,5,6 TETRAHYDRO 3 PYRIDINECARBOXYLIC ACID; 1 [2 [4,4' BIS(TRIFLUOROMETHYL)BENZHYDRYLOXY]ETHYL] 1,2,5,6 TETRAHYDRO 3 PYRIDINECARBOXYLIC ACID; 3 HYDROXY 5 (4 PIPERIDYL)ISOXAZOLE; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID C RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; 4 AMINOBUTYRIC ACID UPTAKE INHIBITOR; BICUCULLINE; GABOXADOL; MUSCIMOL; NIPECOTIC ACID; TIAGABINE; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT;

4 AMINOBUTYRIC ACID UPTAKE; DRUG EFFICACY; DRUG RECEPTOR BINDING; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION;

AMANITA MUSCARIA; BASIDIOMYCOTA;

GABA AGONISTS; MUSCIMOL;

EID: 84918832512     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-014-1245-y     Document Type: Review

References (49)

1. Wieland T (1968) Poisonous principles of mushrooms of the genus Amanita. Science 159:946–952
2. Wasson RG (1968) Soma: Divine Mushroom of Immortality. Harcourt Brace Jovanovich, New York
3. DeFeudis FV (1980) Physiological and behavioral studies with muscimol. Neurochem Res 5:1047–1068
4. Eugster CH, Takemoto T (1967) Zür Nomenclature der neuen Verbindungen aus Amanita-Arten. Helv Chim Acta 50:126–127
5. Johnston GAR, Curtis DR, De Groat WC, Duggan AW (1968) Central actions of ibotenic acid and muscimol. Biochem Pharmacol 17:2488–2489
6. Curtis DR, Hösli L, Johnston GAR (1967) Inhibition of spinal neurons by glycine. Nature 215:1502–1503
7. Curtis DR, Duggan AW, Felix D, Johnston GAR (1971) Bicuculline, an antagonist of GABA and synaptic inhibition in the spinal cord of the cat. Brain Res 32:69–96
8. Johnston GAR, GABA chemistry: Analogs of GABA as therapeutic and investigational agents, in GABA In The Nervous System: The View At Fifty Years, D.L. Martin and R. Olsen, Editors. 2000, Lippincott Williams and Wilkins: Philadelphia. p. 65-80.
9. Brehm L, Hjeds H, Krogsgaard-Larsen P (1972) The structre of muscimol, a GABA analogue of restricted conformation. Acta Chem Scand 26:1298–1299
10. Curtis DR (2006) David R. Curtis Autobiography. The History of Neuroscience in Autobiography 5:171–225
11. Krogsgaard-Larsen P, Johnston GAR, Curtis DR, Game CJA, McCulloch RM (1975) Structure and biological activity of a series of conformationally restricted analogues of GABA. J Neurochem 25:803–809
12. Chebib M, Johnston GAR (2000) GABA-activated ligand gated ion channels: medical chemistry and molecular biology. J Med Chem 43:1427–1447
13. Johnston GAR (2013) Advantages of an antagonist: bicuculline and other GABA antagonists. Br J Pharmacol 169:328–336
14. Beart PM, Curtis DR, Johnston GAR (1971) 4-Aminotetrolic acid: new conformational-restricted analogue of γ-aminobutyric acid. Nature - New Biology 234:80–81
15. Johnston GAR, Curtis DR, Beart PM, Game CJA, McCulloch RM, Twitchin B (1975) Cis- and trans-4-aminocrotonic acid as GABA analogues of restricted conformation. J Neurochem 24:157–160
16. C receptors. Neurochem Res 35:1970–1977
17. 3H-muscimol for GABA receptor studies. Nature 273:392–394
18. Krogsgaard-Larsen P, Johnston GAR (1978) Structure-activity studies on the inhibition of GABA binding to rat brain membranes by muscimol and related compounds. J Neurochem 30:1377–1382
19. Johnston GAR (1971) Muscimol and the uptake of γ-aminobutyric acid by rat brain slices. Psychopharmacologia 22:230–233
20. Johnston GAR, Kennedy SM, Lodge D (1978) Muscimol uptake, release and binding in rat brain slices. J Neurochem 31:1519–1523
21. B receptor agonists and antagonists. Mol Pharmacol 43:609–625
22. Ebert B, Thompson SA, Saounatsou K, McKernan R, Krogsgaard-Larsen P, Wafford KA (1997) Differences in agonist/antagonist binding affinity and receptor transduction using recombinant human γ-aminobutyric acid type A receptors. Mol Pharmacol 52:1150–1156
23. A receptors: Functional selectivity for extrasynaptic receptors is dependent on the absence of gamma2. J Pharmacol Exp Ther 316:1351–1359
24. A receptors. J Physiol 588:1251–1268
25. DeFeudis FV (1980) Binding stuides with muscimol; Relation to synaptic γ-aminobutrate receptors. Neuroscience 5:675–688
26. A receptors. J Neurochem 87:325–332
27. Andrews PR, Johnston GAR (1979) Conformational analysis of muscimol, a GABA agonist. J Theor Biol 79:263–273
28. Bergmann R, Kongsbak K, Sorensen PL, Sander T, Balle T (2013) A unified model of the GABA(A) receptor comprising agonist and benzodiazepine binding sites. PLoS ONE [Electronic Resource] 8:e52323
29. A receptor subtypes indicate a different binding mode for GABA at these receptors. Biochem Pharmacol 84:549–557
30. Krogsgaard-Larsen P, Johnston GAR (1975) Inhibition of GABA uptake in rat brain slices by nipecotic acid, various isoxazoles and related compounds. J Neurochem 25:797–802
31. Brehm L, Krogsgaard-Larsen P, Johnston GAR, Schaumburg K (1976) X-Ray crystallographic and proton magnetic resonance spectorscopic investigations of nipecotic acid, a potent inhibitor of γ-aminobutyric acid (GABA) uptake. Acta Chem. Scand. B 30:542–548
32. Johnston GAR, Stephanson AL, Twitchin B (1976) Uptake and release of nipecotic acid by rat brain slices. J Neurochem 26:83–87
33. Johnston GAR, Krogsgaard-Larsen P, Stephanson AL, Twitchin B (1976) Inhibition of the uptake of GABA and related amino acids in rat brain slices by the optical isomers of nipecotic acid. J Neurochem 26:1029–1032
34. Juhasz G, Kekesi KA, Nyitral G, Dobolyl A, Krogsgaard-Larsen P, Schousboe A (1997) Differential effects of nipecotic acid and 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol on extracellular γ-aminobutyrate levels in rat thalamus. Eur J Pharmacol 331:139–144
35. Falch E, Perregaard J, Frølund B, Sokilde B, Buur A, Hansen LM, Frydenvang K, Brehm L, Bolvig T, Larsson OM, Sanchez C, White HS, Schousboe A, Krogsgaard LP (1999) Selective inhibitors of glial GABA uptake: synthesis, absolute stereochemistry, and pharmacology of the enantiomers of 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole (exo-THPO) and analogues. J Med Chem 42:5402–5414
36. Falch E, Krogsgaard-Larsen P (1989) GABA uptake inhibitors containing mono- and diarylmethoxyalkyl N-subsitutents. Drug Design & Delivery 4:205–215
37. Andersen KE, Braestrup C, Gronwald FC, Jorgensen AS, Nielsen EB, Sonnewald U, Sorensen PO, Suzdak PD, Knutsen LJ (1993) The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4,4-bis(3-methyl)-3-thienyl-3-butenyl]-3-piperidinecarboxylic acid (tiagabine) as an anticonvulsant drug candidate. J Med Chem 36:1716–1725
38. Borden LA, Murali Dhar TG, Smith KE, Weinshank RL, Branchek TA, Gluchowki C (1964) Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1. Eur J Pharmacol 269:219–224
39. Schousboe A, Madsen KK, White HS (2011) GABA transport inhibitors and seizure protection: the past and future. Future Medicinal Chemistry 3:183–187
40. Schousboe A, Madsen KK, Barker-Haliski ML, and White HS (2014) The GABA synapse as a target for antiepileptic drugs: a historical overview focused on GABA transporters. Neurochemical Research: in press this issue
41. Krogsgaard-Larsen P, Johnston GAR, Lodge D, Curtis DR (1977) A new class of GABA agonist. Nature 268:53–55
42. C antagonists. Bioorganic and Medicinal Chemistry 11:4891–4896
43. Skerritt JH, Johnston GAR (1983) Diazepam stimulates the binding of GABA and muscimol but not THIP to rat brain membranes. Neurosci Lett 38:315–320
44. A agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic. Biochem Pharmacol 68:1573–1580
45. Lancel M, Faulhaber J (1996) The GABA(a) agonist THIP (gaboxadol) increases non-rem sleep and enhances delta activity in the rat. NeuroReport 7:2241–2245
46. A receptor agonists. Synthesis and in vitro pharmacology of a series of nonannulated analogs of 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol. J Med Chem 38:3287–3296
47. Frølund B, Tagmose L, Jorgensen AT, Kristiansen U, Stensbol TB, Liljefors T, Krogsgaard-Larsen P (2003) Design and synthesis of a new series of 4-alkylated 3-isoxazolol GABA A antagonists. Eur J Med Chem 38:447–449
48. A receptor ligand Thio-4-PIOL displays distinctly different functional properties at synaptic and extrasynaptic receptors. Br J Pharmacol 170:919–932
49. A receptors with heterocyclic GABA carboxylic acid bioisosteres. Neurochemical Research:in press